Express News | Apellis Pharmaceuticals Inc : UBS Cuts Target Price to $83 From $85

ReutersAug 9 10:12 ET

Wedbush Reaffirms Their Hold Rating on Apellis Pharmaceuticals (APLS)

TipRanksAug 9 09:29 ET · Ratings

Apellis Pharmaceuticals Price Target Raised to $74.00/Share From $66.00 by Goldman Sachs

Dow JonesAug 9 08:07 ET · Ratings

Mizuho Adjusts Apellis Pharmaceuticals' PT to $42 From $40, Keeps Neutral Rating

MT NewswiresAug 9 07:50 ET

Apellis Pharmaceuticals Is Maintained at Outperform by Baird

Dow JonesAug 9 07:25 ET

Express News | Needham Reiterates Buy on Apellis Pharmaceuticals, Maintains $85 Price Target

BenzingaAug 9 06:31 ET